Northern Trust (NTRS) is back in focus after clearing the Federal Reserve’s 2025 stress test, lifting its quarterly dividend, authorising a sizable share repurchase program, and securing approval for a new Ireland banking branch.

Despite a small 1-day share price decline of 1.62% to US$172.11, Northern Trust has built strong momentum, with a 90-day share price return of 25.50% and a 3-year total shareholder return of 164.24%. This reflects how recent dividend increases, buybacks and the Ireland branch approval have contributed to a stronger long term story.

If this combination of capital returns and growth initiatives has you thinking about what else is out there, it might be a good time to widen your search with 20 top founder-led companies

With Northern Trust trading around US$172, close to its analyst price target of US$171 and with only a small implied intrinsic discount, the key question is whether today’s strong run still leaves room for opportunity or if markets are already pricing in future growth.

Most Popular Narrative: 1% Overvalued

The most followed narrative puts Northern Trust's fair value at about $171, just under the last close of $172.11, framing the recent rally as almost fully reflected in the valuation model.

The analysts have a consensus price target of $171.0 for Northern Trust based on their expectations of its future earnings growth, profit margins and other risk factors.

Given the current share price of $172.72, the analyst price target of $171.0 is 1.0% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.

Curious what is driving that tight gap between price and fair value? The narrative leans on modest revenue growth, slightly higher margins and a re-rated earnings multiple that still sits below the broader industry. The focus is on how these factors interact over the next few years.

Result: Fair Value of $171 (OVERVALUED)

However, investors still need to watch for fee pressure from the shift toward passive products and rising technology spend at Northern Trust, which could squeeze margins and test current assumptions.

Another View: Northern Trust Through The P/E Lens

While the main narrative says Northern Trust is about 1% overvalued at a fair value of $171, the P/E picture is mixed. The stock trades on 17.6x earnings, which is much lower than the US Capital Markets industry at 40.6x and below the peer average of 22.6x, yet still above its own fair ratio of 15.3x. That gap suggests investors are paying a premium to where the ratio could settle, even though the stock screens cheaper than peers. This raises the question of whether this is a cushion against downside or a sign expectations have crept ahead of fundamentals.

For a closer look at how this pricing gap might matter over time, it is worth checking the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With Northern Trust, the story so far has mixed signals, so it makes sense to move quickly, check the data yourself and weigh both sides of the debate in the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Northern Trust?

If Northern Trust has sharpened your focus, do not stop here. Broaden your watchlist with other stocks that fit clear, data backed themes using the Simply Wall St screener.

• Target resilient cash generators by scanning companies that show up in the 45 high quality undervalued stocks and decide which ones deserve a closer look.
• Prioritise staying power by checking the solid balance sheet and fundamentals stocks screener (48 results) and see which businesses stand out for financial strength.
• Spot opportunities others might be missing by reviewing the screener containing 19 high quality undiscovered gems before attention and capital potentially move their way.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.